Total Payments
$2,581
2023 Payments
$260.29
Companies
24
Transactions
110
Medicare Patients
4,127
Medicare Billing
$379,814
Payment Breakdown by Category
Food & Beverage$2,581 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,581 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $355.50 | 23 | $0 (2023) |
| Amgen Inc. | $274.87 | 14 | $0 (2020) |
| Novo Nordisk Inc | $247.51 | 14 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $245.20 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $170.09 | 11 | $0 (2023) |
| Amarin Pharma Inc. | $146.87 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $124.73 | 2 | $0 (2021) |
| ABBVIE INC. | $124.58 | 1 | $0 (2022) |
| Lilly USA, LLC | $119.56 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $118.84 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $260.29 | 13 | Lilly USA, LLC ($61.22) |
| 2022 | $410.48 | 11 | ABBVIE INC. ($124.58) |
| 2021 | $240.91 | 6 | Aerie Pharmaceuticals, Inc. ($148.79) |
| 2020 | $152.76 | 9 | Amgen Inc. ($57.10) |
| 2019 | $665.73 | 25 | Amarin Pharma Inc. ($146.87) |
| 2018 | $359.27 | 22 | Novo Nordisk Inc ($127.95) |
| 2017 | $491.79 | 24 | Merck Sharp & Dohme Corporation ($130.89) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Oncology | ||||||
| 11/29/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 10/13/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 09/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.41 | General |
| 08/25/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: VACCINE | ||||||
| 07/11/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Ophthalmology | ||||||
| 06/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $35.24 | General |
| Category: Ophthalmology | ||||||
| 04/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Oncology | ||||||
| 04/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 03/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: INSOMNIA | ||||||
| 11/03/2022 | ABBVIE INC. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $124.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 10/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: PRIMARY CARE | ||||||
| 09/16/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: VACCINE | ||||||
| 07/28/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Diabetes | ||||||
| 07/20/2022 | Alcon Vision LLC | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $68.69 | General |
| Category: Glaucoma | ||||||
| 04/13/2022 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $67.61 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/21/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Ophthalmology | ||||||
| 02/16/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Neuroscience | ||||||
| 01/26/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 07/26/2021 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 1,056 | 1,261 | $286,206 | $94,979 |
| 2022 | 6 | 1,055 | 1,284 | $288,052 | $94,508 |
| 2021 | 5 | 1,030 | 1,168 | $262,151 | $93,914 |
| 2020 | 4 | 986 | 1,237 | $261,900 | $96,413 |
Total Patients
4,127
Total Services
4,950
Medicare Billing
$379,814
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 336 | 447 | $125,160 | $43,420 | 34.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 312 | 392 | $90,160 | $34,002 | 37.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 192 | 201 | $32,160 | $9,450 | 29.4% |
| 92250 | Photography of the retina | Office | 2023 | 182 | 187 | $27,676 | $4,948 | 17.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 34 | 34 | $11,050 | $3,159 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 334 | 455 | $127,400 | $42,197 | 33.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 294 | 366 | $84,180 | $33,374 | 39.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 198 | 217 | $34,720 | $10,293 | 29.6% |
| 92250 | Photography of the retina | Office | 2022 | 185 | 202 | $30,192 | $5,268 | 17.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 31 | 31 | $10,075 | $3,111 | 30.9% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 13 | 13 | $1,485 | $266.32 | 17.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 412 | 519 | $119,370 | $46,461 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 267 | 287 | $81,171 | $30,790 | 37.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 175 | 182 | $29,120 | $9,131 | 31.4% |
| 92250 | Photography of the retina | Office | 2021 | 138 | 142 | $21,016 | $4,124 | 19.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 38 | 38 | $11,474 | $3,407 | 29.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 635 | 882 | $202,860 | $80,243 | 39.6% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 163 | 165 | $26,560 | $7,890 | 29.7% |
| 92250 | Photography of the retina | Office | 2020 | 148 | 150 | $22,200 | $4,809 | 21.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 40 | 40 | $10,280 | $3,472 | 33.8% |
About Dr. John Gambrill, MD
Dr. John Gambrill, MD is a Ophthalmology healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710033022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gambrill, MD has received a total of $2,581 in payments from pharmaceutical and medical device companies, with $260.29 received in 2023. These payments were reported across 110 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,581).
As a Medicare-enrolled provider, Gambrill has provided services to 4,127 Medicare beneficiaries, totaling 4,950 services with total Medicare billing of $379,814. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Catonsville, MD
- Active Since 01/27/2007
- Last Updated 03/19/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710033022
Products in Payments
- Ozempic (Drug) $202.61
- rocklatan (Drug) $193.69
- LUMIGAN (Drug) $157.73
- Vascepa (Drug) $146.87
- TRADJENTA (Drug) $127.63
- INCRUSE (Drug) $118.84
- JANUVIA (Drug) $116.40
- EVENITY (Biological) $103.65
- TRULICITY (Drug) $102.85
- TOUJEO (Drug) $99.98
- PNEUMOVAX 23 (Biological) $97.86
- Rhopressa (Drug) $96.41
- Prolia (Biological) $93.54
- TEGSEDI (Drug) $89.09
- Cequa (Drug) $82.70
- FABRAZYME (Biological) $77.15
- VAXNEUVANCE (Biological) $67.61
- Aimovig (Biological) $65.84
- Edarbyclor (Drug) $49.52
- Edarbi (Drug) $43.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.